RhumbLine Advisers’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.72M Buy
152,749
+1,797
+1% +$32K ﹤0.01% 1718
2025
Q1
$2.69M Buy
150,952
+5,483
+4% +$97.7K ﹤0.01% 1667
2024
Q4
$4.33M Buy
145,469
+3,115
+2% +$92.8K ﹤0.01% 1496
2024
Q3
$2.22M Sell
142,354
-7,765
-5% -$121K ﹤0.01% 1847
2024
Q2
$2.57M Buy
150,119
+37,364
+33% +$640K ﹤0.01% 1753
2024
Q1
$1.76M Sell
112,755
-12,970
-10% -$203K ﹤0.01% 1962
2023
Q4
$1.88M Sell
125,725
-1,300
-1% -$19.4K ﹤0.01% 1941
2023
Q3
$2.05M Sell
127,025
-6,092
-5% -$98.4K ﹤0.01% 1843
2023
Q2
$5.52M Buy
133,117
+15,353
+13% +$637K 0.01% 1316
2023
Q1
$7.08M Buy
117,764
+12,446
+12% +$748K 0.01% 1141
2022
Q4
$7.73M Buy
105,318
+2,393
+2% +$176K 0.01% 1058
2022
Q3
$7.82M Buy
102,925
+5,735
+6% +$436K 0.01% 1016
2022
Q2
$6.76M Buy
97,190
+9,481
+11% +$659K 0.01% 1096
2022
Q1
$7.27M Sell
87,709
-10,254
-10% -$850K 0.01% 1106
2021
Q4
$7.36M Buy
97,963
+3,877
+4% +$291K 0.01% 1155
2021
Q3
$10.9M Sell
94,086
-577
-0.6% -$67K 0.01% 912
2021
Q2
$21M Sell
94,663
-3,811
-4% -$845K 0.03% 577
2021
Q1
$13M Sell
98,474
-6,010
-6% -$794K 0.02% 833
2020
Q4
$18.1M Sell
104,484
-1,331
-1% -$230K 0.03% 593
2020
Q3
$11.8M Sell
105,815
-6,410
-6% -$713K 0.02% 686
2020
Q2
$6.66M Sell
112,225
-9,170
-8% -$544K 0.01% 1020
2020
Q1
$8.18M Buy
121,395
+8
+0% +$539 0.02% 753
2019
Q4
$10.2M Buy
121,387
+6,903
+6% +$582K 0.02% 822
2019
Q3
$8.56M Sell
114,484
-263
-0.2% -$19.7K 0.02% 856
2019
Q2
$7.26M Buy
114,747
+17,057
+17% +$1.08M 0.01% 975
2019
Q1
$4.71M Buy
97,690
+2,155
+2% +$104K 0.01% 1216
2018
Q4
$3.2M Buy
95,535
+29,715
+45% +$995K 0.01% 1369
2018
Q3
$3.45M Sell
65,820
-3,341
-5% -$175K 0.01% 1349
2018
Q2
$2.17M Buy
69,161
+14,651
+27% +$459K ﹤0.01% 1637
2018
Q1
$1.19M Sell
54,510
-830
-1% -$18.1K ﹤0.01% 1862
2017
Q4
$1.12M Sell
55,340
-10,319
-16% -$208K ﹤0.01% 1892
2017
Q3
$1.3M Buy
65,659
+565
+0.9% +$11.2K ﹤0.01% 1849
2017
Q2
$1.13M Buy
65,094
+11,056
+20% +$191K ﹤0.01% 1892
2017
Q1
$438K Buy
54,038
+1,999
+4% +$16.2K ﹤0.01% 2306
2016
Q4
$409K Buy
52,039
+4,960
+11% +$39K ﹤0.01% 2329
2016
Q3
$402K Buy
47,079
+7,508
+19% +$64.1K ﹤0.01% 2324
2016
Q2
$462K Buy
+39,571
New +$462K ﹤0.01% 2243